CoChat

Antianxiety and antidepressant‐like effects of AC‐5216, a novel mitochondrial benzodiazepine receptor ligand

Open access
Kita, Atsuko, Kohayakawa, Hitoshi, Kinoshita, Tomoko, Ochi, Yoshiaki, Nakamichi, Keiko, Kurumiya, Satoshi, Furukawa, Kiyoshi, Oka, Makoto · 2004 · British Journal of Pharmacology
Cited by 125

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

We investigated the ability of N‐benzyl‐N‐ethyl‐2‐(7,8‐dihydro‐7‐methyl‐8‐oxo‐2‐phenyl‐9 H‐purin‐9‐yl)acetamide (AC‐5216), a novel mitochondrial benzodiazepine receptor (MBR) ligand, to produce anti‐anxiety and antidepressant‐like effects in various animal models. AC‐5216 showed high affinity for MBRs prepared from rat whole brain (Ki 0.297 n M), rat glioma cells (IC 50 3.04 n M) and human glioma cells (IC 50 2.73 n M), but only negligible affinity for the other main receptors including central benzodiazepine receptors. AC‐5216 produced anti‐anxiety effects in the Vogel‐type conflict test in rats, and in the light/dark box and social interaction tests in mice at 0.1–3, 0.003–0.01 and 0.01–0.3 mg kg−1, p.o., respectively. These effects of AC‐5216 were antagonized by PK11195, an MBR antagonist. In the forced swimming test in rats, AC‐5216 (3–30 mg kg−1, p.o.) reduced the immobility time, and this effect was blocked by PK11195. AC‐5216 had no myorelaxant effects, did not affect the memory or prolong hexobarbitone‐induced sleep in mice, even at doses as high as 1000 mg kg−1, p.o. Although it did slightly prolong the ethanol‐induced sleep time at 1000 mg kg−1, AC‐5216 (1–100 mg kg−1, p.o.) produced no distinct change in the rat electroencephalogram. These results indicate that AC‐5216 produces anti‐anxiety and antidepressant‐like effects that are mediated by MBR, but does not cause the side effects normally associated with conventional benzodiazepines. Hence, AC‐5216 shows potential for the treatment of stress‐related disorders including anxiety and depression. British Journal of Pharmacology (2004) 142, 1059–1072. doi:10.1038/sj.bjp.0705681

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0705681

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 125

Metadata

Authors
Kita, A., Kohayakawa, H., Kinoshita, T., Ochi, Y., Nakamichi, K., Kurumiya, S., Furukawa, K., & Oka, M.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2004-08
Volume
142
Issue
7
Pages
1059-1072
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2068449302
Cited by
125
References
6
FWCI
0.87
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antianxiety and antidepressant‐like effects of AC‐5216, a novel mitochondrial benzodiazepine receptor ligand. https://app.cochat.ai/papers/10.1038/sj.bjp.0705681
The paper
Kita, A., Kohayakawa, H., Kinoshita, T., Ochi, Y., Nakamichi, K., Kurumiya, S., Furukawa, K., & Oka, M. (2004). Antianxiety and antidepressant‐like effects of AC‐5216, a novel mitochondrial benzodiazepine receptor ligand. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0705681

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.